A key evidence of the role of IL-23 in human pathologies emerged from GWAS analysis showing that a particular coding polymorphism in the IL-23 receptor locus (rs11209026) confers strong protection against inflammatory bowel diseases [110,111] and psoriasis [112]. Here, IL23A is linked to inflammatory bowel disease.